BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Feb 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-01

Reporting Person: Meredith Ian T (EVP/ Global Chief Medical Offi)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-01	Common Stock	M	3130.0000	$0.0000	Acquired	3130.0000	Direct
2018-02-01	Common Stock	F	1088.0000	$27.6300	Disposed	2042.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-01	Deferred Stock Units	$	M	3130.0000	Disposed	2022-02-01	Common Stock (3130.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 1, 2018, the first anniversary of the date of grant.